20th Nov 2023 A plain language summary comparing pegcetacoplan with supportive care for 26 weeks in participants with paroxysmal nocturnal hemoglobinuria
25th Jul 2023 Plain Language Summary: the PEGASUS study comparing pegcetacoplan with eculizumab for 16 weeks in people with paroxysmal nocturnal hemoglobinuria
22nd May 2023 Plain Language Summary: Is ravulizumab a suitable long-term treatment option for patients with paroxysmal nocturnal hemoglobinuria?